journal article·2024-12-21Open access

Curcumin and Metformin Infinite Coordination Polymer Nanoparticles for Combined Therapy of Diabetic Mice via Intraperitoneal Injections

Siwei Sun, Xinyi Hou, Ke Li, Chenqi Huang, Yu Rong, Jiao Bi, Xueping Li, Daocheng Wu

Journal of Functional Biomaterials· Volume 15· Issue 12

Abstract

Metformin (Met) is one of the most commonly prescribed first-line drugs for diabetes treatment. However, it has several issues, including low bioavailability, therapeutic platform, and side effects at high doses. In order to improve the therapeutic efficiency of Met, this study proposes a strategy of using Met and curcumin (Cur) to prepare Cur-Zn(II)-Met infinite coordination polymer nanoparticles (CM ICP NPs), and combining this with intraperitoneal injections, for the treatment of diabetic mice. Fourier transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM), nanoparticle analysis, cytotoxicity experiments, and mice experiments were used to investigate structure, properties, and application effects. The results showed that CM ICP NPs exhibit a high drug encapsulation rate (100%), good stability, and an absence of in vivo and in vitro toxicity. The blood glucose level of diabetic mice after treatment was reduced to 6.7 ± 0.65 mmol/L at the seventh week. In terms of therapeutic mechanism, it appears that Met and Cur can synergistically regulate blood glucose in mice from multiple paths. This study provides a promising method for the treatment of diabetes using Met and other drugs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Metal-Organic Frameworks: Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Basic and Translational Medicine, Xi’an Medical University, Xi’an 710021, China

Xi’an Key Laboratory for Prevention and Treatment of Common Aging Diseases, Translational and Research Centre for Prevention and Therapy of Chronic Disease, Xi’an Medical University, Xi’an 710021, China

School of Pharmacy, Xi’an Medical University, Xi’an 710021, China

Key Laboratory of Biomedical Information Engineering of the Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China

School of Clinical Medicine, Xi’an Medical University, Xi’an 710021, China

Funding

Research and Development Program of the Innovation Chain for Key industries in Shaanxi Province · Natural Science Basic Research Key Program of Shaanxi Province · Special Research Program Project of the Shaanxi Provincial Department of Education · University level Research Fund (Doctoral Project) of Xi’an Medical University

References (69)

Show source-provided references
1. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients10.1186/s12933-022-01548-y ↗
2. Forecasting the type 2 diabetes mellitus epidemic and the role of key risk factors in Oman up to 2050: Mathematical modeling analyses10.1111/jdi.13452 ↗
3. Trends in the burden of type 2 diabetes and its risk factors in Saudi Arabia
4. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes10.1007/s00125-002-1009-0 ↗
5. “Metformin clinical application expert consensus” update expert group (2023). Expert consensus on the clinical application of metformin. Int. J. Endocrinol. Metab., 43, 345–356.
7. Ilias, I., Rizzo, M., and Zabuliene, L. (2022). Metformin: Sex/Gender differences in its uses and effects-narrative review. Medicina, 58.10.3390/medicina58030430 ↗
8. Metformin, chronic nephropathy and lactic acidosis: A multi-faceted issue for the nephrologist10.1007/s40620-020-00941-8 ↗
9. Song, J., He, G.N., and Dai, L. (2023). A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomed. Pharmacother, 162.10.1016/j.biopha.2023.114705 ↗
10. Metformin: Is it a drug for all reasons and diseases?10.1016/j.metabol.2022.155223 ↗
11. Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice10.1007/s00221-021-06176-8 ↗
12. Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis10.1038/s41421-023-00595-3 ↗
13. Chen, Y., Huang, G.D., Qin, T., Zhang, Z.C., Wang, H.L., Xu, Y.T., and Shen, X.N. (2024). Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine. Biomed. Pharmacother., 170.10.1016/j.biopha.2023.116050 ↗
14. Clinical observations and mechanistic insights of traditional Chinese medicine in the management of diabetic retinopathy10.1080/13880209.2024.2369292 ↗
15. Xue, C.X., Chen, Y., Bi, Y.T., Yang, X.F., Chen, K.Y., Tang, C., Tong, X.L., Zhao, L.H., and Wang, H. (2024). Dilemmas in elderly diabetes and clinical practice involving traditional chinese medicine. Pharmaceuticals, 17.10.3390/ph17070953 ↗
16. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells10.1016/j.bbrc.2009.08.018 ↗
17. Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications10.1002/jcp.28528 ↗
18. Jin, T., Feng, J.N., Shao, W., Yang, L., Pang, J., Ling, W.H., Liu, D.H., Wheeler, M., and He, H.S. (2024). Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice. Nutr. Diabetes.10.21203/rs.3.rs-4432933/v1 ↗
19. Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus10.1186/s12933-024-02205-2 ↗
20. Hassan, I., Al-Tamimi, J., Ebaid, H., Habila, M.A., Alhazza, I.M., and Rady, A.M. (2023). Silver nanoparticles decorated with curcumin enhance the efficacy of metformin in diabetic rats via suppression of hepatotoxicity. Toxics, 11.10.3390/toxics11100867 ↗
21. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats10.1186/s13098-019-0431-0 ↗
22. Effects of curcumin and metformin on oxidative stress and apoptosis in heart tissue of type 1 diabetic rats10.34172/jcvtr.2022.23 ↗
23. Rational combinations of targeted cancer therapies: Background, advances and challenges10.1038/s41573-022-00615-z ↗
24. Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: From single to combination therapy10.7150/thno.80687 ↗
25. Four-component of double-layer infinite coordination polymer nanocomposites for large tumor trimodal therapy via multi high-efficiency synergies10.1016/j.jcis.2024.04.039 ↗
26. Self-calibrating Lanthanide infinite coordination polymer constructs fluorescent probes: A sensitive approach for early diagnosis of hepatocellular carcinoma and environmental analysis10.1021/acsami.3c13393 ↗
27. Therapeutic coordination polymers: Tailoring drug release through metal-ligand interactions10.1039/D4SC00732H ↗
28. Coordination bonded stimuli-responsive drug delivery system of chemical actives with metal in pharmaceutical applications10.1016/j.ccr.2024.215851 ↗
29. Detection of anthrax biomarker and metallic ions in aqueous media using spherical-shaped lanthanide infinite coordination polymers10.1016/j.saa.2022.122033 ↗
30. Doxorubicin-Fe(III)-gossypol infinite coordination polymer@PDA:CuO2 composite nanoparticles for cost-effective programmed photothermal chemodynamic-coordinated dual drug chemotherapy trimodal synergistic tumor therapy10.1021/acsnano.3c02401 ↗
31. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress10.1038/s41467-020-20243-8 ↗
32. Weakening the interchain interactions in one dimensional cobalt (II) coordination polymers by preventing intermolecular hydrogen bonding10.1021/acs.inorgchem.3c01324 ↗
33. A luminescent sensor based on in-situ formed copper nanocluster-loading terbium coordination polymer with multicolor response for identification of antibiotics10.1016/j.snb.2023.133904 ↗
34. Therapeutic agent-based infinite coordination polymer nanomedicines for tumor therapy10.1016/j.ccr.2021.214059 ↗
35. Strategies for non-viral vectors targeting organs beyond the liver10.1038/s41565-023-01563-4 ↗
36. Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models10.1016/j.nano.2023.102656 ↗
37. Size-dependent in vivo transport of nanoparticles: Implications for delivery, targeting, and clearance10.1021/acsnano.3c05853 ↗
38. The influence of nanoparticulate drug delivery systems in drug therapy10.1016/j.jddst.2020.101961 ↗
39. Efficacy and side effect profile of different formulations of metformin: A systematic review and meta-analysis10.1007/s13300-021-01058-2 ↗
40. The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice10.18632/aging.203729 ↗
41. Role of particle size in translational research of nanomedicines for successful drug delivery: Discrepancies and inadequacies10.1016/j.xphs.2023.07.002 ↗
42. Metformin and the gastrointestinal tract10.1007/s00125-015-3844-9 ↗
43. Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy10.1016/j.jconrel.2024.04.004 ↗
44. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway10.1016/j.addr.2023.115130 ↗
45. Cytotoxicity, oxidative stress, apoptosis and the autophagic effects of silver nanoparticles in mouse embryonic fibroblasts10.1016/j.biomaterials.2014.02.021 ↗
46. Polydatin protects Schwann cells from methylglyoxal induced cytotoxicity and promotes crushed sciatic nerves regeneration of diabetic rats10.1002/ptr.7177 ↗
47. Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells10.1016/j.ejphar.2009.06.059 ↗
48. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging10.1007/s43440-021-00334-z ↗
49. Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy10.1016/j.colsurfb.2024.114220 ↗
50. Metformin and curcumin co-encapsulated chitosan/alginate nanoparticles as effective oral carriers against pain-like behaviors in mice10.1016/j.ijpharm.2023.123037 ↗
51. The evaluation of renal function and disease in patients with cirrhosis10.1016/j.jhep.2009.11.025 ↗
52. Pivari, F., Mingione, A., Brasacchio, C., and Soldati, L. (2019). Curcumin and type 2 diabetes mellitus: Prevention and treatment. Nutrients, 11.10.3390/nu11081837 ↗
53. Silamiķele, L., Silamiķelis, I., Ustinova, M., Kalniņa, Z., Elbere, I., Petrovska, R., Kalniņa, I., and Kloviņš, J. (2021). Metformin strongly affects gut microbiome composition in high-fat diet-induced Type 2 diabetes mouse model of both sexes. Front. Endocrinol., 12.10.3389/fendo.2021.626359 ↗
54. Synergistic effects of combined anthocyanin and metformin treatment for hyperglycemia In Vitro and In Vivo10.1021/acs.jafc.1c07799 ↗
55. Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model10.1007/s00210-020-01989-w ↗
56. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice10.1038/s41419-021-04184-8 ↗
57. Nanotechnology in diabetes management: Revolutionizing treatment and diagnostics10.1016/j.molliq.2024.126117 ↗
58. Acarbose ameliorates spontaneous type-2 diabetes in db/db mice by inhibiting PDX-1 methylation10.3892/mmr.2020.11710 ↗
59. Wang, X.D., Tian, R., Liang, C.H., Jia, Y.F., Zhao, L.Y., Xie, Q.Y., Huang, F.L., and Yuan, H.J. (2025). Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic β-cell dysfunction for T2DM management. Biomaterials, 313.10.1016/j.biomaterials.2024.122804 ↗
60. Herman, R., Kravos, N.A., Jensterle, M., Janež, A., and Dolžan, V. (2022). Metformin and insulin resistance: A review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport. Int. J. Mol. Sci., 23.10.3390/ijms23031264 ↗
61. Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation10.1016/j.lfs.2007.10.026 ↗
62. Moniruzzaman, M., and Min, T. (2020). Curcumin, curcumin nanoparticles and curcumin nanospheres: A review on their pharmacodynamics based on monogastric farm animal, poultry and fish nutrition. Pharmaceutics, 12.10.3390/pharmaceutics12050447 ↗
63. Role of metformin in the management of polycystic ovary syndrome10.1177/2042018810380215 ↗
64. Metformin in the digestivetract10.1016/S0168-8227(88)80022-6 ↗
65. Curcumin and diabetes: A systematic review10.1155/2013/636053 ↗
66. Glucose controls glucagon secretion by regulating fatty acid oxidation in pancreatic α-cells10.2337/db23-0056 ↗
67. Curcumin attenuates diabetic nephropathy by inhibiting PKC and PKC activity in streptozotocin-induced type I diabetic rats10.1002/mnfr.201100080 ↗
68. Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin
69. Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy10.1038/sj.bjp.0707666 ↗